Seelos Therapeutics Says On Oct. 14 Received Delisting Notice From Nasdaq, Will Transfer Listing To Over-the-Counter Market
Portfolio Pulse from Benzinga Newsdesk
Seelos Therapeutics has received a delisting notice from Nasdaq and will transfer its listing to the Over-the-Counter market.
October 15, 2024 | 1:03 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Seelos Therapeutics has been notified of its delisting from Nasdaq and will transfer its listing to the Over-the-Counter market.
The delisting from Nasdaq is a significant event for Seelos Therapeutics, as it may affect investor perception and liquidity. The move to the Over-the-Counter market typically indicates a downgrade in market status, which could lead to a decrease in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100